ArticleClinical kidney journal2022

Semaglutide in type 2 diabetes with chronic kidney disease at high risk progression-real-world clinical practice.

Beatriz Aviles Bueno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.